Pulse Biosciences Files 8-K

Ticker: PLSE · Form: 8-K · Filed: Sep 2, 2025 · CIK: 1625101

Pulse Biosciences, Inc. 8-K Filing Summary
FieldDetail
CompanyPulse Biosciences, Inc. (PLSE)
Form Type8-K
Filed DateSep 2, 2025
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, 8-k

TL;DR

Pulse Biosciences filed an 8-K, but the details are light in this excerpt.

AI Summary

On September 2, 2025, Pulse Biosciences, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no specific material events or financial figures detailed in the provided excerpt. The report confirms the company's identity and basic filing information.

Why It Matters

This filing indicates Pulse Biosciences is meeting its regulatory reporting obligations. However, the excerpt lacks details on specific business events or financial performance.

Risk Assessment

Risk Level: low — The filing is a routine 8-K with no immediate indication of significant positive or negative events.

Key Players & Entities

  • Pulse Biosciences, Inc. (company) — Registrant
  • 0001437749-25-028093 (filing_id) — Accession Number
  • September 2, 2025 (date) — Date of Earliest Event Reported
  • Delaware (jurisdiction) — State of Incorporation
  • 46-5696597 (ein) — IRS Employer Identification No.
  • 601 Brickell Key Drive, Suite 1080 (address) — Principal Executive Offices
  • Miami (city) — Principal Executive Offices
  • Florida (state) — Principal Executive Offices
  • 33131 (zip_code) — Principal Executive Offices
  • 510 - 906-4600 (phone_number) — Registrant's Telephone Number

FAQ

What is the exact date of the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing is September 2, 2025.

What is the Commission File Number for Pulse Biosciences, Inc.?

The Commission File Number for Pulse Biosciences, Inc. is 001-37744.

What is the IRS Employer Identification Number for Pulse Biosciences, Inc.?

The IRS Employer Identification Number for Pulse Biosciences, Inc. is 46-5696597.

What are the principal executive offices of Pulse Biosciences, Inc.?

The principal executive offices of Pulse Biosciences, Inc. are located at 601 Brickell Key Drive, Suite 1080, Miami, Florida, 33131.

What is the telephone number for Pulse Biosciences, Inc.?

The telephone number for Pulse Biosciences, Inc. is 510-906-4600.

Filing Stats: 473 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2025-09-02 09:03:34

Key Financial Figures

  • $0.001 — nge on Which Registered Common stock , $0.001 par value per share PLSE The Nasdaq

Filing Documents

01

Item 8.01 Other Events. On September 2, 2025, Pulse Biosciences, Inc. issued a press release announcing the first patients enrolled in its multicenter IRB-approved study using its proprietary nsPFA Percutaneous Electrode System for the treatment of benign thyroid nodules (BTNs). A copy of the press release related to the matters set forth herein is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release issued by Pulse Biosciences, Inc. dated September 2, 2025 - Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PULSE BIOSCIENCES, INC. Date: September 2, 2025 By: /s/ Paul A. LaViolette Paul LaViolette Chief Executive Officer (Principal Executive Officer)

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.